首页 > 市场调查报告书 > 医疗设备

医学影像诊断分子呈像/呈影剂

市场调查报告书

商品编码

1271232

诊断用放射性医药品和显影剂市场:各放射性医药品，显影剂(各治疗，各用途)，各地区 - 规模，占有率，展望，机会分析，2023年～2030年

Diagnostic Radiopharmaceuticals and Contrast Media Market, By Radiopharmaceuticals (, By Contrast Media ((by Procedure and by Application ), and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年04月25日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格

简介目录

放射性药物用于生成器官或组织的图像，这一过程称为闪烁显像。同时，造影剂用于成像技术以增强图像上身体组织之间的差异。它是一种用于在医学成像中增加体内结构/流体对比度的物质。

心血管疾病患病率增加、癌症负担增加、诊断中心数量增加、对图像引导程序和诊断的需求增加以及对诊断用放射性药物和造影剂的需求增加，这些都预计是推动全球诊断放射性药物和造影剂市场成长的主要因素。

本报告对全球诊断用放射性药物和造影剂市场进行了深入分析，并提供了预测期(2023-2030年)的市场规模(百万美元)和年复合成长率(CAGR %)，以2022年为基数年。

各治疗
市场规模、预测，YoY成长率，2017-2030年
市场规模与预测，及Yo-Y成长率，2017-2030年
市场规模与预测，及与前一年同期比较成长率，2017年～2030年
各用途
市场规模、预测，及Yo-Y成长率，2017-2030年
市场规模与预测，及Yo-Y成长率，2017-2030年
市场规模与预测，及与前一年同期比较成长率，2017年～2030年
市场规模与预测，及与前一年同期比较成长率，2017年～2030年
市场规模与预测，及与前一年同期比较成长率，2017年～2030年

第7章诊断用放射性医药品和显影剂的全球市场，各地区，2017年～2030年

北美
欧洲
亚太地区
南美
中东、非洲地区

第8章竞争情形

Siemens Healthineers
Nordion Inc.
Lantheus Holdings Inc.
Guerbet Group
GE Healthcare
Curium
Bracco Imaging SpA
Bayer AG
NTP Radioisotopes SOC Ltd.
Cardinal Health Inc.

第9章 Section

关于调查手法
关于出版社

简介目录

Product Code: CMI5666

Radiopharmaceuticals are used to produce images of organs or tissues of interest, a process that is called scintigraphy. While, contrast media is used in imaging techniques to enhance the differences between body tissues on images. It is a substance used to increase the contrast of structures/fluids within the body in medical imaging.

Market Dynamics:

Increase in prevalence of cardiovascular diseases, rise in burden of cancer, increasing number of diagnostic centres, increasing demand for image-guided procedures and diagnostics, and increase in demand for diagnostic radiopharmaceuticals and contrast media, are major factors expected to propel growth of the global diagnostic radiopharmaceuticals and contrast media market.

For instance, in October 2022, Duchem Bio announced the launched of FACBC, the world's first radiopharmaceutical used when diagnosing prostate cancer patients, in Korea. The drug, developed by Nihon Medi Physics, a Japanese pharmaceutical company, is used when conducting positron emission tomography (PET) in patients suspected of having prostate cancer recurrence due to an increase in the prostate-specific antigen (PSA) in the blood after prostate cancer treatment.

Key features of the study:

This report provides in-depth analysis of the global diagnostic radiopharmaceuticals and contrast media market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global diagnostic radiopharmaceuticals and contrast media market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Siemens Healthineers, Nordion Inc., Lantheus Holdings Inc., Guerbet Group, GE Healthcare, Curium, Bracco Imaging SpA, Bayer AG, Cardinal Health Inc., and NTP Radioisotopes SOC Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global diagnostic radiopharmaceuticals and contrast media market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic radiopharmaceuticals and contrast media market.

Detailed Segmentation:

Global Diagnostic Radiopharmaceuticals and Contrast Media Market, By Radiopharmaceuticals
- By Type of Imaging Modality:
  - SPECT
  - PET
- By Application
  - Diagnostic application
  - Therapeutic application
Global Diagnostic Radiopharmaceuticals and Contrast Media Market, By Contrast Media
- By Procedure
  - X-Ray/Computed Tomography (CT)
  - Magnetic Resonance Imaging (MRI)
  - Ultrasound
- By Application
  - Cardiovascular Disease
  - Oncology
  - Gastrointestinal Disorders
  - Neurological Disorders
  - Other Indications
Global Diagnostic Radiopharmaceuticals and Contrast Media Market, By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- Siemens Healthineers
- Nordion Inc.
- Lantheus Holdings Inc.
- Guerbet Group
- GE Healthcare
- Curium
- Bracco Imaging SpA
- Bayer AG
- Cardinal Health Inc.
- NTP Radioisotopes SOC Ltd.

Market Dynamics
- Rise in burden of cardiovascular diseases and cancer worldwide
- Short half-life of radiopharmaceuticals and high costs of the techniques
- Increasing demand for image-guided procedures and diagnostics
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Diagnostic Radiopharmaceuticals and Contrast Media Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Diagnostic Radiopharmaceuticals and Contrast Media Market, By Radiopharmaceuticals, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
By Type of Imaging Modality
- SPECT
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- PET
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
By Application
- Diagnostic Application
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Therapeutic Application
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Diagnostic Radiopharmaceuticals and Contrast Media Market, By Contrast Media, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
By Procedure
- X-Ray/Computed Tomography (CT)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Magnetic Resonance Imaging (MRI)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Ultrasound
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
By Application
- Cardiovascular Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Gastrointestinal Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Neurological Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
- Other Indications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Diagnostic Radiopharmaceuticals and Contrast Media Market, By Geography, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radiopharmaceuticals, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Contrast Media, 2017-2030,(US$ Mn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radiopharmaceuticals, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Contrast Media, 2017-2030,(US$ Mn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radiopharmaceuticals, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Contrast Media, 2017-2030,(US$ Mn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radiopharmaceuticals, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Contrast Media, 2017-2030,(US$ Mn)
Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Radiopharmaceuticals, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Contrast Media, 2017-2030,(US$ Mn)

8. Competitive Landscape

Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nordion Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Lantheus Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Guerbet Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Curium
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bracco Imaging SpA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NTP Radioisotopes SOC Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cardinal Health Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

诊断用放射性医药品和显影剂市场:各放射性医药品，显影剂(各治疗，各用途)，各地区 - 规模，占有率，展望，机会分析，2023年～2030年

Diagnostic Radiopharmaceuticals and Contrast Media Market, By Radiopharmaceuticals (, By Contrast Media ((by Procedure and by Application ), and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030